Enfermedad de Wilson: consideraciones fisiopatológicas, clínicas y terapéuticas

1912, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, Brain, 34, 295, 10.1093/brain/34.4.295 Frydman, 1990, Genetics aspects of Wilson's disease, J Gastroenterol Hepatol, 5, 483, 10.1111/j.1440-1746.1990.tb01427.x Schoen, 1990, Clinical aspects of Wilson's disease, Am J Gastroenterol, 85, 1453 Bull, 1993, The Wilson disease gene is a putative copper transporting P-type ATPase similar to Menkes gene, Nat Genet, 5, 327, 10.1038/ng1293-327 Petrukhin, 1993, Mapping cloning and genetic characterization of the region containing the Wilson disease gene, Nat Genet, 5, 338, 10.1038/ng1293-338 Tanzi, 1993, The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene, Nat Genet, 5, 344, 10.1038/ng1293-344 Maier-Dobersberger, 1997, Detection of the His 1069Glu mutation in Wilson disease by rapid polymerasa chain reaction, Ann Intern Med, 127, 21, 10.7326/0003-4819-127-1-199707010-00004 Czlonkowska, 1997, Very high frequency of the His 1069Glu mutation in Polish Wilson disease patients, J Neurol, 244, 591, 10.1007/s004150050149 Loudianos, 1999, Molecular characterization of Wilson disease in the Sardinian population –evidence of a founder effect, Hum Mutat, 14, 294, 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9 Shah, 1997, Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-fenotype correlation, and functional analysis, Am J Hum Genet, 61, 317, 10.1086/514864 Vulpe, 1995, Cellular copper transport, Annu Rev Nutr, 15, 293, 10.1146/annurev.nu.15.070195.001453 Gollan, 1998, Wilson disease in 1998: genetic, diagnostic and therapeutics aspects, J Hepatol, 28, 28, 10.1016/S0168-8278(98)80373-5 Zhou, 1997, hCTR1: a human gene for copper uptake identified by complementation in yeast, Proc Natl Acad Sci USA, 94, 7481, 10.1073/pnas.94.14.7481 Freedman, 1989, The role of glutathione in copper metabolism toxicity, J Biol Chem, 264, 5598, 10.1016/S0021-9258(18)83589-X Schilsky, 1989, Hepatocellular copper toxicity and its attenuation by zinc, J Clin Invest, 84, 1562, 10.1172/JCI114333 Klomp, 1997, Identification an functional expression of HAH1, a novel human gene involved in copper homeostasis, J Biol Chem, 272, 9332, 10.1074/jbc.272.14.9221 Tereda, 1995, Copper incorporation into ceruloplasmin in rat livers, Biochim Biophys Acta, 1270, 58, 10.1016/0925-4439(94)00072-X Harris, 1995, Aceruloplasminemia: molecular characterization of this disorder of iron metabolism, Proc Natl Acad Sci USA, 92, 2539, 10.1073/pnas.92.7.2539 Hung, 1997, Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae, J Biol Chem, 272, 21461, 10.1074/jbc.272.34.21461 Loudianos, 2000, Wilson's disease, Sem Liver Dis, 20, 353, 10.1055/s-2000-9389 Schaefer, 1999, Location of the Wilson's disease protein in human liver, Gastroenterology, 117, 1380, 10.1016/S0016-5085(99)70288-X Schiefermeier, 2000, The impact of apolipoprotein E genotypes on age and onset of symptoms and phenotypic expression in Wilson's disease, Brain, 123, 585, 10.1093/brain/123.3.585 Gitlin, 1998, Aceruloplasminemia. Review, Pediatr Res, 44, 271, 10.1203/00006450-199809000-00001 Hellman, 2000, Hepatic iron overload in aceruloplasminemia, Gut, 47, 858, 10.1136/gut.47.6.858 Wang, 1996, Wilson disease: asymptomatic or late-onset type, Acta Neurol Scand, 94, 421, 10.1111/j.1600-0404.1996.tb00056.x Thomas, 1995, Wilson disease gene: spectrum of mutations and their consequences, Nat Genet, 9, 210, 10.1038/ng0295-210 Sternlieb, 1968, Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease, Gastroenteroloy, 55, 354, 10.1016/S0016-5085(19)34045-4 Schilsky, 1993, Animal models of copper toxicosis, p357 Berman, 1991, Clinical differentiation of fulminant Wilsonian hepatitis for other causes of hepatic failure, Gastroenterology, 100, 1129, 10.1016/0016-5085(91)90294-U Walshe, 1993, Chelational treatment of neurological Wilson's disease, Q J Med, 86, 197 Starosta-Rubinstein, 1987, Clinical assesment of 31 patients with Wilson'n disease: correlation with structural changes on magnetic resonance imaging, Arch Neurol, 44, 365, 10.1001/archneur.1987.00520160007005 Mochizuki, 1997, Atypical MRI features of Wilson's disease: high signal in globus pallidus on T1-weighted images, Neuroradiology, 39, 171, 10.1007/s002340050386 Saito, 1999, Immunohistochemical determination of the Wilson copper-transporting P-type ATPase in the brain tissues of the rat, Neurosci Lett, 266, 13, 10.1016/S0304-3940(99)00258-X Schilsky, 1994, Liver transplantation for Wilson's disease: indications and outcome, Hepatology, 19, 583, 10.1002/hep.1840190307 Polson, 1987, Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation, Q M Med, 64, 685 Willeit, 1991, Wilson's disease with neurologic impairment but no Kayser-Fleischer rings, Lancet, 337, 1426, 10.1016/0140-6736(91)93123-Q Faa, 1995, Uneven hepatic copper distribution in Wilson disease, J Hepatol, 22, 303, 10.1016/0168-8278(95)80283-5 Steindi, 1997, Wilson's disease in patients presenting with liver disease, Gastroenterology, 113, 212, 10.1016/S0016-5085(97)70097-0 Lyon, 1995, Use of a stable copper isotope (Cu65) in the differential diagnosis of Wilson's disease, Clin Sci, 88, 727, 10.1042/cs0880727 Hitoshi, 1991, Mid-brain pathology of Wilson's disease: MRI analysis of three cases, J Neurol Neurosurg Psychiatry, 54, 624, 10.1136/jnnp.54.7.624 Thomas, 1993, Haplotype studies in Wilson disease, Am J Hum Genet, 54, 71 Maier-Dobersberger, 1995, Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis, Gastroenterology, 109, 2015, 10.1016/0016-5085(95)90771-8 Riordan, 2001, The Wilson's disease gene and phenotypic diversity, J Hepatol, 34, 165, 10.1016/S0168-8278(00)00028-3 Ferenci, 1998, Wilson's disease, Clin Liver Dis, 2, 31, 10.1016/S1089-3261(05)70362-7 Pfeil, 1999, Wilson's disease. Copper unfettered, J Clin Gastroenterol, 29, 22, 10.1097/00004836-199907000-00007 Brewer, 1987, Worsening of neurological syndrome in patients with Wilson's disease with initial penicillamine therapy, Arch Neurol, 44, 490, 10.1001/archneur.1987.00520170020016 Shoulson, 1983, Some therapeutic observations in Wilson's disease, Adv Neurol, 37, 239 Shiono, 2001, Iron acumulation in the liver of male patients with Wilson's disease, Am J Gastroenterol, 96, 3147, 10.1111/j.1572-0241.2001.05269.x Scheinberg, 1987, The use of trientine in preventing the effects of interrupting penicillamine therapy in Willson's disease, N Engl J Med, 31, 209, 10.1056/NEJM198707233170405 Anderson, 1998, Zinc acetate treatment in Wilson's disease, Ann Pharmacother, 32, 78, 10.1345/aph.17075 Brewer, 1991, Initial therapy of patients with Wilson's disease with tetrathiomolybdate, Arch Neurol, 48, 42, 10.1001/archneur.1991.00530130050019 Brewer, 1994, Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in neurologically affected patients, Ach Neurol, 51, 545, 10.1001/archneur.1994.00540180023009 Sokol, 1996, Alpha-tocopherol ameliorates oxidant injury in isolated copper-loaded rat hepatocytes, Pediatr Res, 39, 259, 10.1203/00006450-199602000-00012 Díaz, 1995, Does orthotopic transplantation normalize copper metabolism in patients with Wilson's disease?, Transplant Proc, 27, 2306 Chen, 1997, Neurologic improvement of Wilson's disease after liver transplantation, Transplant Proc, 29, 497, 10.1016/S0041-1345(96)00225-4 Schumacher, 1997, Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease, Clin Transplant, 11, 217 Bax, 1998, Cerebral manifestations of Wilson's disease succesfully treated with liver transplantation, Neurology, 51, 863, 10.1212/WNL.51.3.863 Madsen, 1993, Intractable neurological Wilson's disease treated with orthotopic liver transplantation, Dig Dis Sci, 38, 1746, 10.1007/BF01303186 Kaushansky, 1987, Endocrine studies of the ovulatory disturbances in Wilson's disease (hepatolenticular degeneration), Fertil Steril, 47, 270, 10.1016/S0015-0282(16)50004-1 Klee, 1979, Undiagnosed Wilson's disease as a cause of unexplained miscariage [letter], Lancet, 2, 423, 10.1016/S0140-6736(79)90440-9 Scheinberg, 1975, Pregnancy in penicillamine-treated patients with Wilson's disease, N Engl J Med, 293, 1300, 10.1056/NEJM197512182932507 Sternlieb, 2000, Wilson's disease and pregnancy, Hepatology, 31, 531, 10.1002/hep.510310239 Yarze, 1992, Wilson's disease: Current status, Am J Med, 92, 643, 10.1016/0002-9343(92)90783-8 Brewer, 2000, Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy, Hepatology, 31, 364, 10.1002/hep.510310216 Bunke, 1989, Abweichungen in der Zusammensezung der Muttermilch bei Morbus Wilson, Kinderärztl Prax, 57, 89